Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-045964
Filing Date
2024-11-14
Accepted
2024-11-14 16:38:07
Documents
49
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 2040408
2 ex10-73.htm EX-10.73 68149
3 ex31.htm EX-31 12119
4 ex32.htm EX-32 4182
  Complete submission text file 0001493152-24-045964.txt   6700574

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE clcs-20240930.xsd EX-101.SCH 33101
6 XBRL CALCULATION FILE clcs-20240930_cal.xml EX-101.CAL 37548
7 XBRL DEFINITION FILE clcs-20240930_def.xml EX-101.DEF 237551
8 XBRL LABEL FILE clcs-20240930_lab.xml EX-101.LAB 292650
9 XBRL PRESENTATION FILE clcs-20240930_pre.xml EX-101.PRE 258961
52 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1041397
Mailing Address 57 WEST 57TH STREET SUITE 400 NEW YORK NY 10019
Business Address 57 WEST 57TH STREET SUITE 400 NEW YORK NY 10019 646-612-7554
Cell Source, Inc. (Filer) CIK: 0001569340 (see all company filings)

EIN.: 320379665 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55413 | Film No.: 241463478
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)